⌘K

Home/Filings/4/0001345281-25-000009

4//SEC Filing

DeSantis Damon 4

Accession 0001345281-25-000009

CIK 0001016504other

View on SEC.gov Company Profile

Filed

Jun 19, 8:00 PM ET

Accepted

Jun 20, 2:12 PM ET

Size

5.5 KB

Accession

0001345281-25-000009

Insider Transaction Report

Form 4

Period: 2025-06-18

INTEGRATED BIOPHARMA INCINBP

Director

Transactions

Award
Stock Option (right to buy)
2025-06-18+50,000→ 50,000 total
Exercise: $0.30Exp: 2035-06-18→ Common Stock (50,000 underlying)

Footnotes (1)

[F1]The stock options vest and become exercisable in four equal installments (12,500 stock options each) on each of September 30, 2025, December 31, 2025, March 31, 2026 and June 30, 2026.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

INTEGRATED BIOPHARMA INC

CIK 0001016504

Entity typeother

Related Parties

1

filerCIK 0001889279

Filing Metadata

Form type: 4
Filed: Jun 19, 8:00 PM ET
Accepted: Jun 20, 2:12 PM ET
Size: 5.5 KB

View on SEC.gov